Evidence map›Paper›PMID 35959208›Full record

ArticleOpen forum infectious diseases2022

Clinical Features and Treatment Outcomes of Pulmonary

Grace Wang, Jack T Stapleton, Arthur W Baker, Nadine Rouphael, C Buddy Creech, Hana M El Sahly, Jason E Stout, Lisa Jackson, Edward Charbek, Francisco J Leyva and 12 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Co-infection withFrontiers in medicine · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Grace WangDepartment of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Jack T StapletonDepartment of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
Arthur W BakerDuke University School of Medicine, Durham, North Carolina, USA.
Nadine RouphaelDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-2512-7919
C Buddy CreechVanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Hana M El SahlyBaylor College of Medicine, Human Vaccine Institute, Houston, Texas, USA.
Jason E StoutDuke University School of Medicine, Durham, North Carolina, USA.
Lisa JacksonKaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Edward CharbekDepartment of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Francisco J LeyvaDivision of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Kay M TomashekDivision of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Melinda TibbalsDivision of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
Aaron MillerDepartment of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Sharon FreyDepartment of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Samson NiemotkaDepartment of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Timothy L WiemkenDepartment of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.
Nour BeydounDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Ghina AlaaeddineDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Nicholas TurnerDuke University School of Medicine, Durham, North Carolina, USA.
Emmanuel B WalterDuke University School of Medicine, Durham, North Carolina, USA.
Robin ChamberlandDepartment of Pathology, Division of Clinical Pathology, Saint Louis University School of Medicine, St Louis, Missouri, USA.
Getahun AbateDepartment of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.

Funding

The effects of hepatitis C virus (HCV) E2 protein on host immunomodulationI01BX000207 · VA · IOWA CITY VA MEDICAL CENTER · PI STAPLETON, JACK T. · 2009 to 2025
–
BLRD VA I01 BX000207NIAID NIH HHS HHSN272201300015CNIAID NIH HHS HHSN272201300015INIAID NIH HHS HHSN272201300017CNIAID NIH HHS HHSN272201300017INIAID NIH HHS HHSN272201300018CNIAID NIH HHS HHSN272201300018INIAID NIH HHS HHSN272201300019CNIAID NIH HHS HHSN272201300019INIAID NIH HHS HHSN272201300020INIAID NIH HHS HHSN272201300021CNIAID NIH HHS HHSN272201300021INIAID NIH HHS HHSN272201300023CNIAID NIH HHS HHSN272201300023I
6 · The paper itself

Abstract

Coinfections are more common in patients with cystic fibrosis and bronchiectasis. Infiltrates on imaging studies are seen more commonly in patients with coinfections, but coinfections did not affect treatment outcomes of pulmonary

Identifiers

PMID35959208
PMCPMC9361173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.